Analyst consensus rating
HUTCHMED (China) Analyst Rating: none
Direct answer
HUTCHMED (China)'s consensus rating is none.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $21.14.
Forecast evidence checked November 14, 2026.
Get free HUTCHMED (China) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.90
- Average price target
- $21.14
- High price target
- $33.27
- Low price target
- $13.60
- Low target gap
- -8.7%
- Target upside
- +41.9%
- High target gap
- +123.3%
- Target range width
- 132%
- Consensus rating
- none
- Analysts
- 12
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for HUTCHMED (China)?
HUTCHMED (China) has a verified none consensus. The same dataset has an average price target of $21.14.
How far are HUTCHMED (China)'s low and high targets from the recorded price?
The low target implies -8.7%, while the high target implies +123.3%.
How many analysts are included in HUTCHMED (China)'s consensus?
The verified consensus includes 12 analysts.
How is HUTCHMED (China)'s target upside or downside calculated?
The average target of $21.14 is divided by the recorded price of $14.90, then one is subtracted to produce +41.9%. This does not guarantee a future return.
When was HUTCHMED (China)'s analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.